The Centers for Medicare & Medicaid Services yesterday updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.

For inpatient admissions occurring on or after Sept. 1, 2020, claims eligible for the 20% add-on will be required to have a positive COVID-19 laboratory test documented in patients’ medical records.

Read the AHA Special Bulletin for additional information on this policy’s importance to hospitals and health systems.

Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
The AHA June 9 commented on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system proposed rule…
Headline
The AHA commented June 1 on the Centers for Medicare & Medicaid Services’ skilled nursing facility prospective payment system proposed rule for fiscal year…
Headline
The AHA submitted comments to the Centers for Medicare & Medicaid Services June 1 on the inpatient psychiatric facility prospective payment system proposed…
Headline
The AHA June 1 urged the Centers for Medicare & Medicaid Services to revisit its market basket forecast and work with Congress to reduce the productivity…